Usana Health Sciences Inc - USNA STOCK NEWS

USANA Health Sciences (NYSE: USNA) reported Q1 2025 financial results with net sales of $250 million, up 10% year-over-year. The company saw mixed performance with net earnings declining 43% to $9.4 million and diluted EPS falling to $0.49 from $0.86.

Key metrics include Adjusted EBITDA of $30 million (-10% YoY) and Direct Selling Active Customers of 459,000. The company's Hiya division showed strong performance with 224,000 Active Monthly Subscribers and $37 million in net sales.

USANA reiterated its fiscal year 2025 outlook, projecting consolidated net sales of $920 million to $1.0 billion and adjusted diluted EPS of $2.35 to $3.00. The company repurchased 399,000 shares for $12 million during Q1, with $49 million remaining under current authorization.

Management noted potential challenges from international trade uncertainties and tariffs, particularly regarding raw materials trade between the US and China, though these impacts are not reflected in current guidance.

USANA Health Sciences has announced positive results from a clinical study of its Celavive Resurfacing Serum. The study, involving 33 women aged 39-65 with mild to moderate skin concerns, demonstrated significant skin improvements in just two weeks.

The 12-week study revealed notable improvements including:

• 15.8% reduction in fine lines appearance
• 11.6% reduction in pores appearance
• 23% reduction in acute visible hyperpigmentation
• 8.9% improvement in apparent skin clarity
• 8.6% improvement in skin radiance

The serum, containing alpha/beta hydroxy acids, niacinamide, peptides, and bakuchiol (a natural retinol alternative), was well-tolerated by all participants. Notably, 81.8% of participants reported the best skin feeling in a long time, and 97% would recommend the product.

USANA Health Sciences (NYSE:USNA) has announced its schedule for first quarter 2025 earnings release, set for Tuesday, April 22, 2025, after market close. The company will post its Management Commentary document on their Investor Relations website, followed by a conference call with analysts and institutional investors on Wednesday, April 23, 2025, at 11:00 a.m. Eastern Time.

USANA develops and manufactures nutritional supplements, functional foods and personal care products, distributed through direct sales to Associates and Preferred Customers across 24 countries. The company maintains a 78.8% controlling ownership stake in Hiya Health Products, a children's health and wellness company specializing in clean-label products.

USANA Health Sciences (NYSE: USNA) Executive Chairman Kevin Guest commemorates the convergence of International Guitar Month and Stress Awareness Month in April 2025, highlighting the therapeutic benefits of guitar playing for mental wellness.

Guest, an active guitarist, outlines six key benefits of playing guitar for mental well-being: stress reduction through musical immersion, dopamine release for improved mood, mindfulness promotion, social connection building, creative expression, and better sleep quality.

Drawing from his bestselling book 'All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony', Guest shares personal experiences about music's transformative power in managing anxiety and building relationships. The book's proceeds support child hunger initiatives, with each purchase providing 40 meals.

USANA Health Sciences (NYSE: USNA) Executive Chairman Kevin Guest is promoting March's Listening Awareness Month, sharing personal experiences and practical insights about the transformative power of active listening. Guest, author of 'All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony', emphasizes how listening strengthens relationships both personally and professionally.

Guest shares a personal story about receiving important parenting advice from Denis Waitley and illustrates how listening helped resolve his son's behavioral challenges. He presents three key steps for active listening:

• Seek First to Understand - focusing on comprehension before response
• Listen to Your Inner Voice - being mindful of personal biases
• Lead with Empathy - engaging with both ears and heart

The initiative aligns with USANA's commitment to social wellness across its operations in 25 countries. Notably, proceeds from Guest's book sales contribute to feeding hungry children, with each book providing 40 meals.

USANA Health Sciences (NYSE: USNA) reported Q4 2024 financial results and completed acquisition of 78.8% stake in Hiya Health Products. Q4 net sales decreased to $214M from $221M year-over-year, with net earnings falling to $4.5M from $16.8M. Diluted EPS declined to $0.23 from $0.87.

For full-year 2024, net sales were $855M compared to $921M in 2023, with net earnings of $42.0M versus $63.8M. Active customers decreased to 454,000 from 483,000.

The company provided FY2025 guidance projecting:

• Net sales between $920M-$1.0B (8-17% growth)
• Net earnings of $29M-$41M
• Diluted EPS of $1.50-$2.20

USANA Health Sciences (NYSE: USNA) Executive Chairman Kevin Guest is promoting International Boost Self-Esteem Month this February, sharing personal experiences and strategies for building confidence. Guest, author of 'All the Right Reasons,' recounts how healthy self-esteem helped him overcome a major business setback to eventually lead a billion-dollar global company.

Guest outlines five key strategies for building self-esteem: practicing self-compassion, setting achievable goals, challenging negative thoughts, practicing daily gratitude, and learning assertiveness skills. The initiative aligns with USANA's commitment to health and wellness across its operations in 25 countries since its founding in 1992.

Proceeds from Guest's book sales support hunger relief, with each book purchase providing 40 meals to children in need.

USANA Health Sciences (NYSE: USNA) has appointed Dr. Kathryn Armstrong as its new Chief Scientific Officer. Dr. Armstrong, who has been serving as Executive Vice President of R&D since July 2024, brings 17 years of scientific expertise to the role. She succeeds Dr. Rob Sinnott, who retired at the end of 2024 but will continue as Senior Scientific Fellow.

Dr. Armstrong holds a B.S. in Chemistry from Loyola University Chicago and a Ph.D. in Biochemistry from Notre Dame. Her career includes positions at Whirlpool, BISSELL Homecare, and most recently, Amway, where she spent nearly nine years in various roles including VP of new ventures. In her new role, she will lead a team of approximately 150 professionals across product development, regulatory affairs, quality control, research, and laboratory services.

USANA Health Sciences (NYSE: USNA) has announced its schedule for the release of fourth quarter and fiscal year 2024 financial results. The company will release its earnings after market close on February 25, 2025, followed by the posting of a Management Commentary document on their investor relations website.

A conference call with analysts and institutional investors is scheduled for February 26, 2025, at 11:00 a.m. Eastern Time. USANA develops and manufactures nutritional supplements, functional foods, and personal care products, selling directly through Associates and Preferred Customers across multiple international markets. The company also holds a 78.8% controlling stake in Hiya Health Products, a children's health and wellness company.